0

CORTRAK for Feeding Tube Placement Verification in Enteral Nutrition

AM
MF
Overseen ByMegan Foster, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center at San Antonio
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial will compare the accuracy of the CORTRAK system to x-rays in locating feeding tubes in pediatric patients who are already receiving x-rays as part of their routine care.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Is the CORTRAK system safe for feeding tube placement?

The CORTRAK system is generally considered safe for feeding tube placement, but it requires trained users to avoid complications like pneumothorax (air in the space around the lungs). Some studies suggest that user expertise is crucial for safe use.12345

How is the CORTRAK Stylet treatment different from other feeding tube placement methods?

The CORTRAK Stylet is unique because it uses electromagnetic guidance to place feeding tubes, allowing for real-time visualization and potentially eliminating the need for X-ray confirmation. This method can be performed at the bedside by trained nurses, making it more convenient and cost-effective compared to traditional endoscopic or radiological placement methods.12456

What data supports the effectiveness of the treatment CORTRAK Stylet for feeding tube placement verification in enteral nutrition?

Research shows that the CORTRAK Enteral Access System (CEAS) is effective in placing feeding tubes, with an 83% success rate in positioning nasojejunal tubes in ICU patients. It is a simple bedside tool that can reduce the need for X-ray confirmation, saving time and costs.12567

Who Is on the Research Team?

AM

Andrew Meyer, MD

Principal Investigator

University of Texas Health at San Antonio

Are You a Good Fit for This Trial?

This trial is for pediatric patients (17 or younger) who are receiving enteral nutrition and need their feeding tube position confirmed. They must be getting an x-ray for any reason and have a CORTRAK Stylet available in the room. The study excludes those where the CORTRAK Stylet has been misplaced.

Inclusion Criteria

You recently had an X-ray for any reason.
I have a CORTRAK feeding tube installed.
I am 17 years old or younger.
See 1 more

Exclusion Criteria

The CORTRAK Stylet has been inserted incorrectly.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Comparison of feeding tube placement accuracy using CORTRAK system versus X-ray

10-14 days
Inpatient monitoring

Follow-up

Participants are monitored for safety and effectiveness after treatment

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • CORTRAK Stylet
Trial Overview The study is testing how well the CORTRAK enteral access system can confirm the correct placement of feeding tubes in the abdomen compared to traditional x-ray methods.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Feeding Tube Placement using CORTRAK styletActive Control1 Intervention
Group II: Feeding Tube Placement using X-RayActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center at San Antonio

Lead Sponsor

Trials
486
Recruited
92,500+

Published Research Related to This Trial

The CORTRAK enteral access system (CEAS) was successfully used to place nasojejunal feeding tubes in all 56 critically ill patients, including those with low platelet counts and anticoagulation therapy, indicating its efficacy and safety in challenging clinical situations.
While epistaxis (nosebleeds) occurred in 48.2% of patients, most cases were mild, and no severe bleeding complications were reported, suggesting that CEAS can be safely used even in patients with thrombocytopenia.
The feasibility of electromagnetic sensing aided post pyloric feeding tube placement (CORTRAK) in patients with thrombocytopenia with or without anticoagulation on the intensive care unit.Stecher, SS., Barnikel, M., Drolle, H., et al.[2022]
The Cortrak Enteral Access System (CEAS) successfully placed nasojejunal tubes in 83% of patients in an ICU setting, demonstrating its effectiveness for ensuring enteral nutrition despite challenges like decreased gastric emptying.
Using the CEAS for tube placement took about 30 minutes and allowed for enteral feeding to continue for 2 to 15 days, highlighting its potential as a cost-effective and efficient method for delivering nutrition in critically ill patients.
An evaluation of the Cortrak Enteral access system in our intensive care.Dolan, AM., O'Hanlon, C., O'Rourke, J.[2019]
The Cortrak® feeding tube, which is placed at the bedside using electromagnetic guidance, could potentially replace traditional endoscopic methods for at least 25% of duodenal tube placements in a hospital setting, based on a review of 487 placements in 331 patients.
As the use of Cortrak® becomes more routine, it is estimated that over 50% of patients needing naso-duodenal feeding tubes, including those in ICU, could qualify for this method, suggesting a significant opportunity for improved patient care and efficiency.
Cortrak&#174; duodenal tube placements: A solution for more patients? A&#160;preliminary survey to the introduction of electromagnetic-guided placement of naso-duodenal feeding tubes.Arjaans, W., Ouwehand, M., Bouma, G., et al.[2020]

Citations

Small-bore feeding tubes placed with an electromagnetic imaging device leads to cost avoidance and decreased time to initiation of enteral nutrition. [2023]
The feasibility of electromagnetic sensing aided post pyloric feeding tube placement (CORTRAK) in patients with thrombocytopenia with or without anticoagulation on the intensive care unit. [2022]
Nasopharyngeal perforation by a new electromagnetically visualised enteral feeding tube. [2021]
An evaluation of the Cortrak Enteral access system in our intensive care. [2019]
Cortrak&#174; duodenal tube placements: A solution for more patients? A&#160;preliminary survey to the introduction of electromagnetic-guided placement of naso-duodenal feeding tubes. [2020]
Cortrak-Assisted Feeding Tube Insertion: A Comprehensive Review of Adverse Events in the MAUDE Database. [2018]
CORTRAK Superuser Competency Assessment and Training Recommendations. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security